Royal Bank Of Canada Raises Calian Group (TSE:CGY) Price Target to C$60.00

Calian Group (TSE:CGYGet Free Report) had its price target increased by Royal Bank Of Canada from C$58.00 to C$60.00 in a report released on Friday,BayStreet.CA reports. The brokerage currently has an “outperform” rating on the stock. Royal Bank Of Canada’s price objective suggests a potential downside of 15.01% from the stock’s current price.

A number of other research firms also recently weighed in on CGY. Canadian Imperial Bank of Commerce raised their price target on shares of Calian Group from C$65.00 to C$76.00 in a research report on Friday. Ventum Financial boosted their target price on shares of Calian Group from C$62.00 to C$72.00 and gave the stock a “buy” rating in a research report on Tuesday, January 27th. Canaccord Genuity Group upped their target price on shares of Calian Group from C$63.00 to C$80.00 in a research note on Friday. Finally, Desjardins lifted their price target on Calian Group from C$59.00 to C$66.00 and gave the stock a “buy” rating in a research note on Thursday, November 27th. Six investment analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the company presently has an average rating of “Buy” and a consensus price target of C$74.83.

Read Our Latest Analysis on CGY

Calian Group Stock Up 6.7%

Shares of TSE CGY opened at C$70.60 on Friday. The company has a debt-to-equity ratio of 39.54, a quick ratio of 1.20 and a current ratio of 1.29. Calian Group has a 1 year low of C$37.70 and a 1 year high of C$71.92. The stock’s 50-day simple moving average is C$60.38 and its 200-day simple moving average is C$54.13. The firm has a market cap of C$805.62 million, a price-to-earnings ratio of 40.11, a PEG ratio of 2.50 and a beta of 0.70.

Calian Group (TSE:CGYGet Free Report) last issued its quarterly earnings data on Thursday, February 12th. The company reported C$1.03 earnings per share for the quarter. Calian Group had a return on equity of 3.37% and a net margin of 1.50%.The firm had revenue of C$208.00 million during the quarter. As a group, equities analysts anticipate that Calian Group will post 4.9475219 earnings per share for the current fiscal year.

Key Stories Impacting Calian Group

Here are the key news stories impacting Calian Group this week:

  • Positive Sentiment: Record Q1 results — Calian reported C$208M revenue (up ~12% YoY) with margin gains and C$1.03 EPS, and management signaled confident growth on the earnings call; this strengthens the growth narrative driving buying interest. Calian Delivers Record Q1 Revenue and Margin Gains
  • Positive Sentiment: Multiple analyst target upgrades — Acumen (to C$85, Buy), Canaccord (to C$80), CIBC (to C$76) and Ventum (to C$82, Buy) raised price targets, signaling broad analyst optimism and providing upward catalyst for the stock. Analyst Ratings Roundup
  • Positive Sentiment: Quarterly dividend declared — Board approved a C$0.28 quarterly dividend (annualized yield ~1.6%), with ex-dividend Feb 25 and record Mar 11; supports shareholder return profile and can attract income-minded buyers.
  • Neutral Sentiment: Corporate governance update — Shareholders re‑elected the board and named Valerie Sorbie as Chair, which preserves leadership continuity but is unlikely to move the stock materially by itself. Shareholder Meeting Results
  • Negative Sentiment: RBC’s moderate target bump to C$60 — Although RBC maintained an “outperform” stance, its target remains well below the current price, indicating at least one major analyst sees less upside and creating potential resistance or caution among some investors. RBC Target Update

Calian Group Company Profile

(Get Free Report)

Calian Group Ltd operates through four segments namely Advanced Technologies, Health, Learning, and Information Technology. It generates maximum revenue from the Health segment. The company serves health, defence, security, aerospace, engineering, AgTech, and IT industries. Its Health segment includes Clinical Services; Nursing Services; Psychological Services and Medical Property Management. The Advanced Technologies segment includes Engineering Solutions and Services; Nuclear and Environmental Services; Satcom; DOCSIS; Electronics Design and Manufacturing and Agricultural Technology.

Featured Articles

Analyst Recommendations for Calian Group (TSE:CGY)

Receive News & Ratings for Calian Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calian Group and related companies with MarketBeat.com's FREE daily email newsletter.